Metabotropic glutamate receptor ligands are protective in experimental animal models of Parkinson's disease

被引：0
|
作者：
Battaglia, G
Fornai, F
Busceti, CL
Bovolin, P
Bruno, V
Nicoletti, F
机构：
[1] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy
[2] Univ Turin, Dept Human & Anim Biol, Turin, Italy
[3] Univ Pisa, Dept Human Morphol & Appl Biol, Pisa, Italy
来源：
NEUROPHARMACOLOGY | 2002年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
11
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [21] Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson's disease
    Lee, J. Y.
    Kim, Y. K.
    Shin, S. A.
    Seo, S. H.
    Lee, J. S.
    Lee, Y. S.
    Jeong, J. M.
    Jeon, B.
    MOVEMENT DISORDERS, 2018, 33 : S692 - S692
  • [22] Role of the metabotropic glutamate receptor on Huntington's disease
    Ribeiro, F. M.
    Anborgh, P. H.
    Cregan, T.
    Ferguson, S. S.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 198 - 198
  • [23] Surcellular and subsynaptic localization of group I metabotropic glutamate receptors in the subthalamic nucleus of normal animals and animal models of Parkinson's disease
    Kuwajima, M
    Hubert, GW
    Smith, Y
    NEUROPHARMACOLOGY, 2002, 43 (02) : 293 - 293
  • [24] A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease
    Le Poul, Emmanuel
    Bolea, Christelle
    Girard, Francoise
    Poli, Sonia
    Charvin, Delphine
    Campo, Brice
    Bortoli, Julien
    Bessif, Abdhelak
    Luo, Bin
    Koser, Amy Jo
    Hodge, Lisa M.
    Smith, Karen M.
    DiLella, Anthony G.
    Liverton, Nigel
    Hess, Fred
    Browne, Susan E.
    Reynolds, Ian J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 343 (01): : 167 - 177
  • [25] Effects of group I metabotropic glutamate receptor antagonists in rat models of Parkinson's disease and L-DOPA-induced dyskinesia
    Dekundy, A
    Pietraszek, M
    Schaefer, D
    Danysz, W
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S69 - S69
  • [26] Effects of the blockade of subtype 1 metabotropic glutamate receptors (mGIuRs) in models of Parkinson's disease in the rat
    Ossowska, K
    Wardas, J
    Konieczny, J
    Pietraszek, M
    Zapala, M
    Wolfarth, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S370 - S370
  • [27] Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease
    Bonsi, P.
    Cuomo, D.
    Picconi, B.
    Sciamanna, G.
    Tscherter, A.
    Tolu, M.
    Bernardi, G.
    Calabresi, P.
    Pisani, A.
    AMINO ACIDS, 2007, 32 (02) : 189 - 195
  • [28] Functional and cellular effects of metabotropic glutamate receptor 5 blockade in a rat model of Parkinson's disease
    Breysse, N
    Salin, P
    Baunez, C
    Amalric, M
    NEUROPHARMACOLOGY, 2002, 43 (02) : 278 - 279
  • [29] Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease
    P. Bonsi
    D. Cuomo
    B. Picconi
    G. Sciamanna
    A. Tscherter
    M. Tolu
    G. Bernardi
    P. Calabresi
    A. Pisani
    Amino Acids, 2007, 32 : 189 - 195
  • [30] Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: Behavioral and histological analyses
    Agari, Takashi
    Yasuhara, Takao
    Matsui, Toshihiro
    Kuramoto, Satoshi
    Kondo, Akihiko
    Miyoshi, Yasuyuki
    Shingo, Tetsuro
    Borlongan, Cesario V.
    Date, Isao
    BRAIN RESEARCH, 2008, 1203 : 189 - 196
12345